Background: Chronic periodontitis and gingivitis are associated with various diseases; however, their impact on dementia is yet to be elucidated. This study is aimed at investigating the association between chronic periodontitis and gingivitis, and the risk of developing dementia. Methods: A total of 2,207 patients, with newly diagnosed chronic periodontitis and gingivitis between January 1, 2000 and December 31, 2000, were selected from the National Health Insurance Research Database of Taiwan, along with 6,621 controls matched for sex and age. After adjusting for confounding factors, Cox proportional hazards analysis was used to compare the risk of developing dementia during the 10-year follow-up period. Results: Of the study subjects, 25 (1.13%) developed dementia compared to 61 (0.92%) in the control group. Cox proportional hazards regression analysis revealed that the study subjects were more likely to develop dementia (hazard ratio (HR) 2.085, 95% CI 1.552-4.156, p < 0.001). After adjusting for sex, age, monthly income, urbanization level, geographic region, and comorbidities, the HR for dementia was 2.54 (95% CI 1.297-3.352, p = 0.002). Conclusions: Patients with chronic periodontitis and gingivitis have a higher risk of developing dementia. However, further studies on other large or national data sets are required to support the current findings.

1.
World Health Organization: Dementia cases set to triple by 2050 but still largely ignored. http://www.who.int/mediacentre/news/releases/2012/dementia_20120411/en/index.html.
2.
Taiwan Alzheimer's Disease Association: 2015-2056 Expected Dementia Population Report in Taiwan. http://www.tada2002.org.tw/tada_know_02.html#01.
3.
Katon W, Pedersen HS, Ribe AR, Fenger-Grøn M, Davydow D, Waldorff FB, Vestergaard M: Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry 2015;72:612-619.
4.
Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P: Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 2006;5:64-74.
5.
Huang CC, Chung CM, Leu HB, Lin LY, Chiu CC, Hsu CY, Chiang CH, Huang PH, Chen TJ, Lin SJ, et al: Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study. PLoS One 2014;9:e87095.
6.
Sharp SI, Aarsland D, Day S, Sønnesyn H; Alzheimer's Society Vascular Dementia Systematic Review Group, Ballard C: Hypertension is a potential risk factor for vascular dementia: systematic review. Int J Geriatr Psychiatry 2011;26:661-669.
7.
Moreno Cervantes C, Mimenza Alvarado A, Aguilar Navarro S, Alvarado Ávila P, Gutiérrez Gutiérrez L, Juárez Arellano S, Ávila Funes JA: Factors associated with mixed dementia vs Alzheimer disease in elderly Mexican adults. Neurologia 2016;pii:S0213-4853(16)00018-9.
8.
Vanhanen M, Koivisto K, Moilanen L, Helkala EL, Hänninen T, Soininen H, Kervinen K, Kesäniemi YA, Laakso M, Kuusisto J: Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology 2006;67:843-847.
9.
Chiang CJ, Yip PK, Wu SC, Lu CS, Liou CW, Liu HC, Liu CK, Chu CH, Hwang CS, Sung SF, et al: Midlife risk factors for subtypes of dementia: a nested case-control study in Taiwan. Am J Geriatr Psychiatry 2007;15:762-771.
10.
Kivipelto M, Ngandu T, Fratiglioni L, Viitanen M, Kåreholt I, Winblad B, Helkala EL, Tuomilehto J, Soininen H, Nissinen A: Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease. Arch Neurol 2005;62:1556-1560.
11.
Burke SL, Maramaldi P, Cadet T, Kukull W: Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia. Int Psychogeriatr 2016;28:1409-1424.
12.
Chen MH, Li CT, Tsai CF, Lin WC, Chang WH, Chen TJ, Pan TL, Su TP, Bai YM: Risk of subsequent dementia among patients with bipolar disorder or major depression: a nationwide longitudinal study in Taiwan. J Am Med Dir Assoc 2015;16:504-508.
13.
Lee YK, Hou SW, Lee CC, Hsu CY, Huang YS, Su YC: Increased risk of dementia in patients with mild traumatic brain injury: a nationwide cohort study. PLoS One 2013;8:e62422.
14.
Wang HK, Lin SH, Sung PS, Wu MH, Hung KW, Wang LC, Huang CY, Lu K, Chen HJ, Tsai KJ: Population based study on patients with traumatic brain injury suggests increased risk of dementia. J Neurol Neurosurg Psychiatry 2012;83:1080-1085.
15.
Huang CY, Li YC, Wang HK, Sung PS, Wang LC, Sun YT, Pan CH, Tsai KJ: Stroke suggests increased risk of dementia. Curr Alzheimer Res 2015;12:287-295.
16.
Desmond DW, Moroney JT, Sano M, Stern Y: Incidence of dementia after ischemic stroke: results of a longitudinal study. Stroke 2002;33:2254-2260.
17.
Miwa K, Tanaka M, Okazaki S, Furukado S, Yagita Y, Sakaguchi M, Mochizuki H, Kitagawa K: Chronic kidney disease is associated with dementia independent of cerebral small-vessel disease. Neurology 2014;82:1051-1057.
18.
Helmer C, Stengel B, Metzger M, Froissart M, Massy ZA, Tzourio C, Berr C, Dartigues JF: Chronic kidney disease, cognitive decline, and incident dementia: the 3C study. Neurology 2011;77:2043-2051.
19.
Kao LT, Sheu JJ, Lin HC, Tsai MC, Chung SD: Association between sepsis and dementia. J Clin Neurosci 2015;22:1430-1433.
20.
Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC: Hepatitis C viral infection and the risk of dementia. Eur J Neurol 2014;21:1068-e59.
21.
Huang WS, Yang TY, Shen WC, Lin CL, Lin MC, Kao CH: Association between Helicobacter pylori infection and dementia. J Clin Neurosci 2014;21:1355-1358.
22.
Tseng CH, Huang WS, Muo CH, Kao CH: Increased risk of dementia among chronic osteomyelitis patients. Eur J Clin Microbiol Infect Dis 2015;34:153-159.
23.
Azizi G, Navabi SS, Al-Shukaili A, Seyedzadeh MH, Yazdani R, Mirshafiey A: The role of inflammatory mediators in the pathogenesis of Alzheimer's disease. Sultan Qaboos Univ Med J 2015;15:e305-e316.
24.
Daulatzai MA: Fundamental role of pan-inflammation and oxidative-nitrosative pathways in neuropathogenesis of Alzheimer's disease. Am J Neurodegener Dis 2016;5:1-28.
25.
Stefaniak J, O'Brien J: Imaging of neuroinflammation in dementia: a review. J Neurol Neurosurg Psychiatry 2016;87:21-28.
26.
Bokhari SA, Khan AA, Leung WK, Wajid G: Association of periodontal and cardiovascular diseases: South-Asian studies 2001-2012. J Indian Soc Periodontol 2015;19:495-500.
27.
Papapanou PN: Systemic effects of periodontitis: lessons learned from research on atherosclerotic vascular disease and adverse pregnancy outcomes. Int Dent J 2015;65:283-291.
28.
Taylor GW, Borgnakke WS: Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis 2008;14:191-203.
29.
Perrino MA: Diabetes and periodontal disease: an example of an oral/systemic relationship. N Y State Dent J 2007;73:38-41.
30.
Mojon P: Oral health and respiratory infection. J Can Dent Assoc 2002;68:340-345.
31.
Bansal M, Khatri M, Taneja V: Potential role of periodontal infection in respiratory diseases - a review. J Med Life 2013;6:244-248.
32.
Sánchez AR, Kupp LI, Sheridan PJ, Sánchez DR: Maternal chronic infection as a risk factor in preterm low birth weight infants: the link with periodontal infection. J Int Acad Periodontol 2004;6:89-94.
33.
Khader Y, Al-shishani L, Obeidat B, Khassawneh M, Burgan S, Amarin ZO, Alomari M, Alkafajei A: Maternal periodontal status and preterm low birth weight delivery: a case-control study. Arch Gynecol Obstet 2009;279:165-169.
34.
Cicciù M, Risitano G, Lo Giudice G, Bramanti E: Periodontal health and caries prevalence evaluation in patients affected by Parkinson's disease. Parkinsons Dis 2012;2012:541908.
35.
Bramanti E, Bramanti A, Matacena G, Bramanti P, Rizzi A, Cicciù M: Clinical evaluation of the oral health status in vascular-type dementia patients. A case-control study. Minerva Stomatol 2015;64:167-175.
36.
Cicciù M, Matacena G, Signorino F, Brugaletta A, Cicciù A, Bramanti E: Relationship between oral health and its impact on the quality life of Alzheimer's disease patients: a supportive care trial. Int J Clin Exp Med 2013;6:766-772.
37.
Allareddy V, Prakasam S, Allareddy V, Martinez-Schlurmann NI, Rampa S, Nalliah RP, Eswaran SV, Elangovan S: Poor oral health linked with increased risk of infectious complications in adults with leukemia. J Mass Dent Soc 2015;64:38-42.
38.
Chen HH, Chen DY, Lai KL, Chen YM, Chou YJ, Chou P, Lin CH, Huang N: Periodontitis and etanercept discontinuation risk in anti-tumor necrosis factor-naive rheumatoid arthritis patients: a nationwide population-based cohort study. J Clin Rheumatol 2013;19:432-438.
39.
Allareddy V, Elangovan S, Rampa S, Shin K, Nalliah RP, Allareddy V: Presence of gingivitis and periodontitis significantly increases hospital charges in patients undergoing heart valve surgery. J Mass Dent Soc 2015;63:10-16.
40.
Liu TC, Sheu JJ, Lin HC, Jensen DA: Increased risk of parkinsonism following chronic periodontitis: a retrospective cohort study. Mov Disord 2013;28:1307-1308.
41.
National Health Insurance Research Database. http://nhird.nhri.org.tw/en/Data_Subsets.html.
42.
Ho Chan WS: Taiwan's healthcare report 2010. EPMA J 2010;1:563-585.
43.
Association CH: ICD-9-CM English-Chinese Dictionary. Taipei, Chinese Hospital Association Press, 2000.
44.
Cheng CY, Tsai CF, Wang SJ, Hsu CY, Fuh JL: Sleep disturbance correlates with white matter hyperintensity in patients with subcortical ischemic vascular dementia. J Geriatr Psychiatry Neurol 2013;26:158-164.
45.
Hsu JL, Fan YC, Huang YL, Wang J, Chen WH, Chiu HC, Bai CH: Improved predictive ability of the Montreal Cognitive Assessment for diagnosing dementia in a community-based study. Alzheimers Res Ther 2015;7:69.
46.
Wu YT, Lee HY, Norton S, Chen C, Chen H, He C, Fleming J, Matthews FE, Brayne C: Prevalence studies of dementia in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis. PLoS One 2013;8:e66252.
47.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), Fourth Edition. American Psychiatric Association, 1994.
48.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR), Fourth Edition, Text Revision. American Psychiatric Association, 2000.
49.
Chen HL, Lee YP, Young SC, Wu CY: A summary report of concurrent peer review of inpatient medical records in a medical center. Taiwan J Public Health 1995;14:103-110.
50.
Bureau of National Health Insurance Regulations. http://www.nhi.gov.tw/information/bulletin_file/421_0890036465-19.doc.
51.
Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML: Validation of the national health insurance research database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf 2011;20:236-242.
52.
Chou IC, Lin HC, Lin CC, Sung FC, Kao CH: Tourette syndrome and risk of depression: a population-based cohort study in Taiwan. J Dev Behav Pediatr 2013;34:181-185.
53.
Liang JA, Sun LM, Muo CH, Sung FC, Chang SN, Kao CH: The analysis of depression and subsequent cancer risk in Taiwan. Cancer Epidemiol Biomarkers Prev 2011;20:473-475.
54.
Chang CY, Chen WL, Liou YF, Ke CC, Lee HC, Huang HL, Ciou LP, Chou CC, Yang MC, Ho SY, et al: Increased risk of major depression in the three years following a femoral neck fracture - a national population-based follow-up study. PLoS One 2014;9:e89867.
55.
Hong JY, Lan TY, Tang GJ, Tang CH, Chen TJ, Lin HY: Gout and the risk of dementia: a nationwide population-based cohort study. Arthritis Res Ther 2015;17:139.
56.
Yang FC, Lin TY, Chen HJ, Lee JT, Lin CC, Kao CH: Increased risk of dementia in patients with tension-type headache: a nationwide retrospective population-based cohort study. PLoS One 2016;11:e0156097.
57.
Shih HI, Lin CC, Tu YF, Chang CM, Hsu HC, Chi CH, Kao CH: An increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control study. Medicine (Baltimore) 2015;94:e809.
58.
Sun YH, Nfor ON, Huang JY, Liaw YP: Association between dental amalgam fillings and Alzheimer's disease: a population-based cross-sectional study in Taiwan. Alzheimers Res Ther 2015;7:65.
59.
Chu CH, Ng A, Chau AM, Lo EC: Oral health status of elderly Chinese with dementia in Hong Kong. Oral Health Prev Dent 2015;3:51-57.
60.
Einarsdóttir ER, Gunnsteinsdóttir H, Hallsdóttir MH, Sveinsson S, Jónsdóttir SR, Olafsson VG, Bragason TH, Saemundsson SR, Holbrook WP: Dental health of patients with Parkinson's disease in Iceland. Spec Care Dentist 2009;29:123-127.
61.
Müller T, Palluch R, Jackowski J: Caries and periodontal disease in patients with Parkinson's disease. Spec Care Dentist 2011;31:178-181.
62.
Iadecola C: The pathobiology of vascular dementia. Neuron 2013;80:844-866.
63.
Liu HC, Lin KN, Teng EL, Wang SJ, Fuh JL, Guo NW, Chou P, Hu HH, Chiang BN: Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals. J Am Geriatr Soc 1995;43:144-149.
64.
Liu CK, Lai CL, Tai CT, Lin RT, Yen YY, Howng SL: Incidence and subtypes of dementia in southern Taiwan: impact of socio-demographic factors. Neurology 1998;50:1572-1579.
65.
Lin RT, Lai CL, Tai CT, Liu CK, Yen YY, Howng SL: Prevalence and subtypes of dementia in southern Taiwan: impact of age, sex, education, and urbanization. J Neurol Sci 1998;160:67-75.
66.
Zhang ZX, Zahner GE, Román GC, Liu J, Hong Z, Qu QM, Liu XH, Zhang XJ, Zhou B, Wu CB, et al: Dementia subtypes in China: prevalence in Beijing, Xian, Shanghai, and Chengdu. Arch Neurol 2005;62:447-453.
67.
Dong MJ, Peng B, Lin XT, Zhao J, Zhou YR, Wang RH: The prevalence of dementia in the People's Republic of China: a systematic analysis of 1980-2004 studies. Age Ageing 2007;36:619-624.
68.
Sun Y, Lee HJ, Yang SC, Chen TF, Lin KN, Lin CC, Wang PN, Tang LY, Chiu MJ: A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan. PLoS One 2014;9:e100303.
69.
The Ministry of Health and Welfare's Survey on Dementia Reminds the Public of the Importance of Recognizing Dementia Patients in Their Communities; The Government Has Also Launched a Plan for the Long-term Care for Dementia Patients in Communities. http://www.mohw.gov.tw/EN/Ministry/DM2_P.aspx?f_list_no=378&fod_list_no=4999&doc_no=46642.
70.
Abbayya K, Puthanakar NY, Naduwinmani S, Chidambar YS: Association between periodontitis and Alzheimer's disease. N Am J Med Sci 2015;7:241-246.
71.
Farhad SZ, Amini S, Khalilian A, Barekatain M, Mafi M, Barekatain M, Rafei E: The effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in Alzheimer disease. Dent Res J (Isfahan) 2014;11:549-552.
72.
Gaur S, Agnihotri R: Alzheimer's disease and chronic periodontitis: is there an association? Geriatr Gerontol Int 2015;15:391-404.
73.
Noble JM, Scarmeas N, Celenti RS, Elkind MS, Wright CB, Schupf N, Papapanou PN: Serum IgG antibody levels to periodontal microbiota are associated with incident Alzheimer disease. PLoS One 2014;9:e114959.
74.
Olsen I, Singhrao SK: Can oral infection be a risk factor for Alzheimer's disease? J Oral Microbiol 2015;7:29143.
75.
Wu Z, Nakanishi H: Lessons from microglia aging for the link between inflammatory bone disorders and Alzheimer's disease. J Immunol Res 2015;2015:471342.
76.
Singhrao SK, Harding A, Simmons T, Robinson S, Kesavalu L, Crean S: Oral inflammation, tooth loss, risk factors, and association with progression of Alzheimer's disease. J Alzheimers Dis 2014;42:723-737.
77.
Ide M, Harris M, Stevens A, Sussams R, Hopkins V, Culliford D, Fuller J, Ibbett P, Raybould R, Thomas R, et al: Periodontitis and cognitive decline in Alzheimer's disease. PLoS One 2016;11:e0151081.
78.
Martande SS, Pradeep AR, Singh SP, Kumari M, Suke DK, Raju AP, Naik SB, Singh P, Guruprasad CN, Chatterji A: Periodontal health condition in patients with Alzheimer's disease. Am J Alzheimers Dis Other Demen 2014;29:498-502.
79.
Astafurov K, Elhawy E, Ren L, Dong CQ, Igboin C, Hyman L, Griffen A, Mittag T, Danias J: Oral microbiome link to neurodegeneration in glaucoma. PLoS One 2014;9:e104416.
80.
Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, Perry VH: Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:788-789.
81.
D'Aiuto F, Graziani F, Tetè S, Gabriele M, Tonetti MS: Periodontitis: from local infection to systemic diseases. Int J Immunopathol Pharmacol 2005;18(3 suppl):1-11.
82.
Wang LW, Chang YC, Lin CY, Hong JS, Huang CC: Low-dose lipopolysaccharide selectively sensitizes hypoxic ischemia-induced white matter injury in the immature brain. Pediatr Res 2010;68:41-47.
83.
Ghosh A, Birngruber T, Sattler W, Kroath T, Ratzer M, Sinner F, Pieber TR: Assessment of blood-brain barrier function and the neuroinflammatory response in the rat brain by using cerebral open flow microperfusion (cOFM). PLoS One 2014;9:e98143.
84.
Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A, Sancarlo D, Vendemiale G, Pilotto A, Panza F: Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res Rev 2010;9:399-417.
85.
Panza F, Frisardi V, Seripa D, Imbimbo BP, Sancarlo D, D'Onofrio G, Addante F, Paris F, Pilotto A, Solfrizzi V: Metabolic syndrome, mild cognitive impairment, and dementia. Curr Alzheimer Res 2011;8:492-509.
86.
Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, et al: Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis 2010;21:691-724.
87.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.